loader
Find a Test

Parathyroid Hormone (PTH)

Order Code
16365
CPT
83970
Test Details
Synonyms

Intact PTH, Parathormone, Parathyrin

TAT

24 hours

Methodology

Electrochemiluminescence Immunoassay (ECLIA)

Performing Location

Accredited NRL Laboratory

Testing Frequency

Daily

Test Overview

The NRL assay measures intact PTH. The clinical utility of measuring PTH lies in evaluating calcium and phosphate balance and diagnosing parathyroid and bone disorders. In cases of hypercalcemia, PTH distinguishes primary hyperparathyroidism (elevated or inappropriately normal PTH with high calcium) from hypercalcemia of malignancy (suppressed PTH). In cases of hypocalcemia, PTH Identifies hypoparathyroidism (low PTH with low calcium) resulting from autoimmune destruction, genetic disorders, or prior neck surgery. In cases of CKD (chronic kideny disease), PTH Monitors secondary hyperparathyroidism caused by phosphate retention and low active vitamin D production.

Specimen Type

Plasma

Volume

0.5 mL

Specimen Container

EDTA Plasma (Lavender Top)

Patient Preparation

No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider.

Collection

This test does not require any special collection or pre-analytical handling. Follow routine specimen collection protocols.

Specimen Stability
Temperature Period
Refrigerated 2 days at 2-8°C
Frozen 6 months at -20°C
Order Code
16365
CPT
83970
Test Details
Synonyms

Intact PTH, Parathormone, Parathyrin

TAT

24 hours

Methodology

Electrochemiluminescence Immunoassay (ECLIA)

Performing Location

Accredited NRL Laboratory

Testing Frequency

Daily

Test Overview

The NRL assay measures intact PTH. The clinical utility of measuring PTH lies in evaluating calcium and phosphate balance and diagnosing parathyroid and bone disorders. In cases of hypercalcemia, PTH distinguishes primary hyperparathyroidism (elevated or inappropriately normal PTH with high calcium) from hypercalcemia of malignancy (suppressed PTH). In cases of hypocalcemia, PTH Identifies hypoparathyroidism (low PTH with low calcium) resulting from autoimmune destruction, genetic disorders, or prior neck surgery. In cases of CKD (chronic kideny disease), PTH Monitors secondary hyperparathyroidism caused by phosphate retention and low active vitamin D production.

Specimen Type

Plasma

Volume

0.5 mL

Specimen Container

EDTA Plasma (Lavender Top)

Patient Preparation

No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider.

Collection

This test does not require any special collection or pre-analytical handling. Follow routine specimen collection protocols.

Specimen Stability
Temperature Period
Refrigerated 2 days at 2-8°C
Frozen 6 months at -20°C